• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测2型糖尿病患者的高血压:列线图模型的见解

Predicting hypertension in type 2 diabetes mellitus: Insights from a nomogram model.

作者信息

Liu Jie, Zhang Nan, Liu Tong

机构信息

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China.

出版信息

World J Diabetes. 2025 Jul 15;16(7):107501. doi: 10.4239/wjd.v16.i7.107501.

DOI:10.4239/wjd.v16.i7.107501
PMID:40697588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12278073/
Abstract

The prevalence of type 2 diabetes mellitus (T2DM) is rising, with hypertension as a common comorbidity that significantly increases cardiovascular and microvascular risks. Accurate prediction of hypertension in T2DM is essential for early intervention and personalized management. In this editorial, we comment on a recent retrospective study by Zhao , which developed a nomogram model using a large cohort of 26850 patients to predict hypertension risk in patients with T2DM. The model incorporated key independent risk factors, including age, body mass index, duration of diabetes, low-density lipoprotein cholesterol and urine protein levels, demonstrating promising discriminative power and predictive accuracy in internal validation. However, its external applicability requires further confirmation. This editorial discusses the clinical value and limitations of the predictive model, highlighting the unfavorable impact of hypertension on T2DM patients. Future research should evaluate the potential contribution of other risk factors to enhance risk prediction and improve the management of T2DM comorbidities.

摘要

2型糖尿病(T2DM)的患病率正在上升,高血压是一种常见的合并症,会显著增加心血管和微血管风险。准确预测T2DM患者的高血压情况对于早期干预和个性化管理至关重要。在这篇社论中,我们对赵等人最近的一项回顾性研究进行评论,该研究使用26850名患者的大型队列开发了一种列线图模型,以预测T2DM患者的高血压风险。该模型纳入了关键的独立危险因素,包括年龄、体重指数、糖尿病病程、低密度脂蛋白胆固醇和尿蛋白水平,在内部验证中显示出有前景的鉴别能力和预测准确性。然而,其外部适用性需要进一步证实。这篇社论讨论了该预测模型的临床价值和局限性,强调了高血压对T2DM患者的不利影响。未来的研究应评估其他危险因素的潜在贡献,以加强风险预测并改善T2DM合并症的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d543/12278073/18432058016f/wjd-16-7-107501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d543/12278073/602d340b0941/wjd-16-7-107501-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d543/12278073/18432058016f/wjd-16-7-107501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d543/12278073/602d340b0941/wjd-16-7-107501-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d543/12278073/18432058016f/wjd-16-7-107501-g002.jpg

相似文献

1
Predicting hypertension in type 2 diabetes mellitus: Insights from a nomogram model.预测2型糖尿病患者的高血压:列线图模型的见解
World J Diabetes. 2025 Jul 15;16(7):107501. doi: 10.4239/wjd.v16.i7.107501.
2
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.
3
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.糖尿病合并妊娠:内分泌学会与欧洲内分泌学会联合临床实践指南
J Clin Endocrinol Metab. 2025 Jul 13. doi: 10.1210/clinem/dgaf288.
4
[Association between obesity and the risk of microvascular complications in Yinzhou District, Ningbo adults with type 2 diabetes mellitus].[宁波鄞州区2型糖尿病成年患者肥胖与微血管并发症风险的相关性]
Wei Sheng Yan Jiu. 2025 Jul;54(4):608-620. doi: 10.19813/j.cnki.weishengyanjiu.2025.04.012.
5
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
6
Clinical value of serum uric acid and homocysteine levels in predicting the occurrence of atrial fibrillation in patients with type 2 diabetes mellitus.血清尿酸和同型半胱氨酸水平对预测2型糖尿病患者房颤发生的临床价值
Biomed Eng Online. 2025 Jul 9;24(1):86. doi: 10.1186/s12938-025-01418-0.
7
AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study.基于人工智能的心脏CT衰减扫描检测肝脂肪变性及综合肝脏评估可增强全因死亡风险分层:一项多中心研究
medRxiv. 2025 Jun 11:2025.06.09.25329157. doi: 10.1101/2025.06.09.25329157.
8
Systemic Inflammatory Response Syndrome全身炎症反应综合征
9
Incremental predictive value of liver fat fraction based on spectral detector CT for major adverse cardiovascular events in T2DM patients with suspected coronary artery disease.基于光谱探测器CT的肝脏脂肪分数对疑似冠心病的2型糖尿病患者主要不良心血管事件的增量预测价值。
Cardiovasc Diabetol. 2025 Apr 2;24(1):151. doi: 10.1186/s12933-025-02704-w.
10
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.二肽基肽酶(DPP)-4抑制剂和胰高血糖素样肽(GLP)-1类似物用于预防或延缓2型糖尿病高危人群发生2型糖尿病及其相关并发症。
Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2.

本文引用的文献

1
Construction of a risk prediction model for hypertension in type 2 diabetes: Independent risk factors and nomogram.2型糖尿病患者高血压风险预测模型的构建:独立危险因素与列线图
World J Diabetes. 2025 May 15;16(5):102141. doi: 10.4239/wjd.v16.i5.102141.
2
Association of the triglyceride glucose index with obesity indicators and hypertension in American adults based on NHANES 2013 to 2018.基于2013至2018年美国国家健康与营养检查调查(NHANES)的美国成年人甘油三酯葡萄糖指数与肥胖指标及高血压的关联
Sci Rep. 2025 Jan 19;15(1):2443. doi: 10.1038/s41598-025-86430-z.
3
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025.
10. 心血管疾病与风险管理:2025年糖尿病护理标准。
Diabetes Care. 2025 Jan 1;48(Supplement_1):S207-S238. doi: 10.2337/dc25-S010.
4
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.2型糖尿病患者的强化血压控制
N Engl J Med. 2025 Mar 27;392(12):1155-1167. doi: 10.1056/NEJMoa2412006. Epub 2024 Nov 16.
5
Chinese expert consensus on the management of hypertension in adults with type 2 diabetes.《中国成人2型糖尿病合并高血压管理专家共识》
J Evid Based Med. 2024 Dec;17(4):851-864. doi: 10.1111/jebm.12655. Epub 2024 Nov 12.
6
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.2024年欧洲心脏病学会高血压管理指南
Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
7
Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study.使用 NT-proBNP 检测 2 型糖尿病伴高血压或血压正常高值患者的心脏应激:一项横断面多中心研究。
Cardiovasc Diabetol. 2024 Aug 12;23(1):297. doi: 10.1186/s12933-024-02391-z.
8
Prevalence and co-prevalence of comorbidities among Chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database.基于 3B 研究数据库的横断面、多中心、回顾性、观察性研究:中国成年 2 型糖尿病患者合并症的患病率和共患病率。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1362433. doi: 10.3389/fendo.2024.1362433. eCollection 2024.
9
Association between a metabolic score for insulin resistance and hypertension: results from National Health and Nutrition Examination Survey 2007-2016 analyses.胰岛素抵抗代谢评分与高血压的相关性:基于 2007-2016 年全国健康与营养调查的分析结果。
Front Endocrinol (Lausanne). 2024 Apr 22;15:1369600. doi: 10.3389/fendo.2024.1369600. eCollection 2024.
10
Cytokines, C-Reactive Protein, and Risk of Incident Hypertension in the REGARDS Study.细胞因子、C 反应蛋白与 REGARDS 研究中高血压事件发生风险的关系。
Hypertension. 2024 Jun;81(6):1244-1253. doi: 10.1161/HYPERTENSIONAHA.123.22714. Epub 2024 Mar 15.